Last10K.com

Acro Biomedical Co., Ltd. (ACBM) SEC Filing 8-K Material Event for the period ending Friday, July 6, 2018

Acro Biomedical Co., Ltd.

CIK: 1622996 Ticker: ACBM

View differences made from one to another to evaluate Acro Biomedical Co., Ltd.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Acro Biomedical Co., Ltd..

Continue

Assess how Acro Biomedical Co., Ltd.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Acro Biomedical Co., Ltd.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: ACBM
CIK: 1622996
Form Type: 8-K Corporate News
Accession Number: 0001640334-18-001322
Submitted to the SEC: Fri Jul 06 2018 2:35:37 PM EST
Accepted by the SEC: Fri Jul 06 2018
Period: Friday, July 6, 2018
Industry: Amusement And Recreation Services
Events:
  1. Accountant Change

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/acbm/0001640334-18-001322.htm